The 2010 WADA Prohibited List: Summary of Revisions |
The ISSF would like to alert all its shooters and member federations that the World Anti-Doping Agency (WADA) has released the 2010 Prohibited List. The new List comes into effect January 1, 2010.
The ISSF highlights the following changes for all shooters, ISSF Member Federations and medical staff. | |
|
|
1. The status of Salbutamol has changed
Following several years of practice and consideration of all relevant information, there has been a change in status of the beta-2 agonist salbutamol, a substance listed as a specified substance in the 2009 List. This is because over the past few years, almost all cases where salbutamol has been detected were covered by Therapeutic Use Exemptions (TUEs).
In the 2010 List, the therapeutic use of inhaled salbutamol will not be prohibited and will therefore no longer require a TUE. For monitoring purposes, shooters using inhaled salbutamol will be required to declare their use on the Doping Control Form when they are tested or on a separate Declaration of use Form prior to testing to avoid any omissions.
Salbutamol will still be prohibited for urinary concentrations above 1,000 nanograms per milliliter. In such cases, there will be a presumption that the substance was not taken by inhalation and the shooter will have the burden to demonstrate that the level found in his urine was the result of therapeutic inhaled use.
| |
|
|
2. Follow-up testing is no longer necessary for elevated T/E Ratios.
In the past when a shooter’s sample yielded an elevated testosterone to epitestosterone ratio, at least 2 further tests were necessary to confirm that the source of the elevated T/E ratio was endogenous (natural). As of January 1, 2010, no further collections or analyses will be required in cases where the testosterone to epitestosterone (T/E) ratio of a shooter is greater than 4 and an isotope ratio mass spectrometry (IRMS) test or any other reliable analytical method has not revealed evidence of exogenous administration of a prohibited substance.
| |
|
|
3. Pseudoephedrine is reintroduced on the List.
Until 2003, pseudoephedrine was prohibited in all sports. Then from 2004 on, it was simply annually included in WADA’s Monitoring Program. (The Monitoring Program includes substances that are not prohibited in sport but are monitored by anti-doping laboratories in order to detect patterns of misuse.)
Results of the Monitoring Program over the past five years have shown a sustained increase in samples containing pseudoephedrine, a clear abuse of this substance with high concentrations in a number of sports and regions, and scientific evidence of the performance-enhancing effects of pseudoephedrine beyond certain doses. Based on theses results pseudoephedrine will be prohibited above 150 micrograms per milliliter.
| |
|
|
4. Supplement oxygen for medical reasons is not prohibited
The 2010 List clarifies that supplemental oxygen (hyperoxia) is not prohibited.
| |
|
|
5. Platelet-Derived Preparations prohibited when administered via muscles.
The status of platelet-derived preparations (e.g. Platelet Rich Plasma, “blood spinning”) has been clarified. These preparations will be prohibited when administered by intramuscular route. Other routes of administration will require a Declaration of Use in compliance with the International Standard for TUEs.
| |
|
|
Links: |
|
|
The 2009 WADA Prohibited List: Summary of Revisions |
The ISSF would like to alert all its shooters and member federations that the World Anti-Doping Agency (WADA) has released the 2009 Prohibited List. The new List comes into effect January 1, 2009.
WADA has summarized the differences from the 2008 list in an explanatory note. The ISSF would like to highlight certain changes for all Shooters.
| |
|
|
1. Athletes that use the prohibited substances found in asthma medications for medically justified reasons will follow a different approval process.
The Abbreviated Therapeutic Use Exemption (ATUE) process has been discontinued. Athletes that use beta-2 agonists and glucocorticosteroids will see a new combination of declarations through ADAMS and on their doping control form, and a requirement to maintain a medical file that supports the use of the substance. The file is to be submitted to either the ISSF or to their NADO (National Anti-Doping Organisation), either in advance of competition or retroactively upon request. A variety of factors, such as the athlete’s level and the route of administration, determine the exact process. We advise you to contact the ISSF or your NADO for more information. | |
|
|
2. A large number of substances on the Prohibited List have been reclassified as “specified substances” because they are considered to be generally available in medicinal products or less likely to be abused as doping agents.
Only anabolic agents and hormones, some stimulants, certain hormone antagonists and modulators, and all prohibited methods are NOT in this category. The effect of this change will be primarily reflected in the results management process, when the duration of a sanction will be determined from within a range of time based on the factors pertinent to each case. | |
|
|
3. Alpha reductase inhibitors are no longer prohibited
They have been rendered ineffective as masking agents by closer consideration of steroid profiles. An example of these types of inhibitors is finasteride, which is commonly used in the treatment of male pattern baldness and is currently sold in many countries under the brand names Propecia and Proscar. | |
|
|
4. Intravenous infusions are still prohibited and require a TUE, but a list of exceptions is provided.
The list of non-prohibited medical uses of intravenous infusions includes the management of surgical procedures, medical emergencies or clinical investigations, and injections with a simple syringe if the substance is not prohibited and is less than 50 ml. | |
|
|
Links: |
|
|